Prognostic factors correlated with survival in AIDS patients

被引:6
作者
Casari, S [1 ]
Donisi, A [1 ]
Paraninfo, G [1 ]
Tomasoni, D [1 ]
Palvarini, L [1 ]
Nasta, P [1 ]
Bergamasco, A [1 ]
Cadeo, GP [1 ]
Carosi, G [1 ]
机构
[1] Univ Brescia, Infect & Trop Dis Clin, Brescia, Italy
关键词
AIDS; prognostic factors; survival;
D O I
10.1023/A:1007676625117
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The authors present the AIDS cases (CDC '93) observed in Brescia from 1983 to 1994. They observed 1189 subjects (M 84%, F 16%) with a mean age of 32.7 years (intra-venous drug users 75.1%, heterosexuals 14%, homosexuals 9.6%). The mean survival observed was 56.7 weeks from the diagnosis of AIDS (mortality per year 78%). The most frequent AIDS-defining events were Visceral Candidiasis, P.carinii Pneumonia (PCP) and Neurotoxoplasmosis, while the longest and shortest mean survival was for Kaposi's Sarcoma (89 weeks) and Wasting Syndrome (8.4). The mean value of CD4+ lymphocyte counts on AIDS diagnosis was 72.6/mu l (1166 cases) and the highest and lowest were in non-Hodgkin's Lymphoma (NHL; 147.6/mu l) and Cryptosporidiosis (18.8/mu l). Antiretroviral therapy had been given for at least a month in 41.4% subjects (mean treatment duration of 74.8 weeks). The Cox model has demonstrated the favourable effect on survival of high CD4+ lymphocyte counts on diagnosis, antiretroviral therapy, the diagnosis of Tuberculosis (TBC) and PCP as initial markers and the diagnosis of TBC, PCP or Cytomegalovirus infection (CMV) during the entire clinical evolution. Moreover, the unfavourable effect of high age, diagnosis of Progressive Multifocal Leucoencephalopathy (PML), Wasting Syndrome and NHL as initial markers and diagnosis of PML or NHL in any moment of the disease has been demonstrated.
引用
收藏
页码:691 / 698
页数:8
相关论文
共 21 条
[1]   PROGNOSTIC FACTORS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS WITH A CD4(+) LYMPHOCYTE COUNT LESS-THAN-50/MU-L [J].
APOLONIO, EG ;
HOOVER, DR ;
HE, YH ;
SAAH, AJ ;
LYTER, DW ;
DETELS, R ;
KASLOW, RA ;
PHAIR, JP .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :829-836
[2]   PREDICTORS OF THE SURVIVAL OF AIDS CASES IN BARCELONA, SPAIN [J].
BATALLA, J ;
GATELL, JM ;
CAYLA, JA ;
PLASENCIA, A ;
JANSA, JM ;
PARELLADA, N .
AIDS, 1989, 3 (06) :355-359
[3]   THE PREDICTIVE VALUE OF T-CELL FUNCTION IN-VITRO AND PRE-AIDS ZIDOVUDINE USE FOR SURVIVAL AFTER AIDS DIAGNOSIS IN A COHORT OF HOMOSEXUAL MEN IN AMSTERDAM [J].
BINDELS, PJE ;
KROL, A ;
ROOS, M ;
VEENSTRA, J ;
VANDENHOEK, JAR ;
MIEDEMA, F ;
COUTINHO, RA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) :97-104
[4]   RACE, SEX, DRUG-USE, AND PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE [J].
CHAISSON, RE ;
KERULY, JC ;
MOORE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) :751-756
[5]  
DARMINIOMONFORT.A, 1992, GIORN ITAL AIDS, V3, P85
[6]   MORTALITY AND SURVIVAL TRENDS IN PATIENTS WITH AIDS IN NORTH-EAST ENGLAND FROM 1984-1992 [J].
DORRELL, L ;
SNOW, MH ;
ONG, ELC .
JOURNAL OF INFECTION, 1995, 30 (01) :23-27
[7]   Survival from early, intermediate, and late stages of HIV infection [J].
Enger, C ;
Graham, N ;
Peng, Y ;
Chmiel, JS ;
Kingsley, LA ;
Detels, R ;
Munoz, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (17) :1329-1334
[8]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[9]  
FRIEDLAND GH, 1991, J ACQ IMMUN DEF SYND, V4, P144
[10]   LACK OF ASSOCIATION BETWEEN ACYCLOVIR USE AND SURVIVAL IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE [J].
GALLANT, JE ;
MOORE, RD ;
KERULY, J ;
RICHMAN, DD ;
CHAISSON, RE ;
BARTLETT, J ;
MCAVINUE, S ;
BRYSON, Y ;
COHEN, H ;
FISCHL, M ;
BOLIN, T ;
KESSLER, H ;
BURROUGH, Y ;
MILDVAN, D ;
FOX, A ;
RICHMAN, D ;
FREEMAN, B ;
SIMON, G ;
GRABOWY, KW ;
CHERNOFF, D ;
DUFF, P ;
THOMPSON, S ;
BARRETT, K ;
AWE, R ;
CHAPMAN, R ;
LEONARD, S ;
TURNER, P ;
HAWKINS, M ;
MURRAY, H ;
BOWERS, J ;
LANE, C ;
TILSON, H ;
ANDREWS, E ;
SMILEY, L .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02) :346-352